Duloxetine: A Viewpoint by Richard J. Millard

ISSN： 0012-6667

Source： Drugs, Vol.64, Iss.22, 2004-01, pp. : 2574-2575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Moxifloxacin: A Viewpoint by Richard Wise

By Wise R.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 374-374

Adis International

Access to resources Recommend Favorite

Daptomycin: A Viewpoint by Richard Quintiliani

By Quintiliani R.

Drugs, Vol. 64, Iss. 4, 2004-01 ,pp. : 457-458

Adis International

Access to resources Recommend Favorite

Bicalutamide: A Viewpoint by Richard K. Lo

By Lo R.K.

Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. : 2482-2483

Adis International

Access to resources Recommend Favorite

Atomoxetine: A Viewpoint by J. Elia

By Elia J.

Pediatric Drugs, Vol. 5, Iss. 6, 2003-01 ,pp. : 416-417

Adis International

Access to resources Recommend Favorite

Sunitinib: A Viewpoint by Robert J. Motzer

By Motzer Robert J.

Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. : 2267-2268

Adis International

Access to resources Recommend Favorite